Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Martin

Showing results (671-680 of 842) with videos related to

Pageof 85
Sort By:
The American Journal of Pathology|July 11, 2014
Reduced FOXO1 expression accelerates skin wound healing and attenuates scarringRyoichi Mori, Katsuya Tanaka, Maiko de Kerckhove, et al.
Journal of Clinical and Translational Hepatology|January 15, 2021
Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis BJoseph K Lim, Alex Y Chang, Atif Zaman, et al.
EMBO Molecular Medicine|August 26, 2018
Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axisAlexander Greenhough, Clare Bagley, Kate J Heesom, et al.
Blood|March 6, 2002
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in childrenAnn E Woolfrey, Claudio Anasetti, Barry Storer, et al.
Scientific Reports|December 21, 2023
Identification of differences in CD4<sup>+</sup> T-cell gene expression between people with asthma and healthy controlsMauro Tutino, Jenny Hankinson, Clare Murray, et al.
Gastroenterology|August 2, 2003
6-thioguanine can cause serious liver injury in inflammatory bowel disease patientsMarla C Dubinsky, Eric A Vasiliauskas, Hardeep Singh, et al.
Gastroenterology|June 10, 2006
Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis BMorris Sherman, Cihan Yurdaydin, Jose Sollano, et al.
Plos One|October 4, 2011
CYP17A1 intron mutation causing cryptic splicing in 17α-hydroxylase deficiencyDaw-Yang Hwang, Chi-Chih Hung, Felix G Riepe, et al.
Cancer|June 29, 2019
Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinomaLynn G Feun, Ying-Ying Li, Chunjing Wu, et al.
Elife|May 18, 2021
Live-imaging of endothelial Erk activity reveals dynamic and sequential signalling events during regenerative angiogenesisKazuhide S Okuda, Mikaela S Keyser, David B Gurevich, et al.
Pageof 85

Showing results (671-680 of 842) with videos related to

Sort By:
Pageof 85
The American Journal of Pathology|July 11, 2014
Reduced FOXO1 expression accelerates skin wound healing and attenuates scarringRyoichi Mori, Katsuya Tanaka, Maiko de Kerckhove, et al.
Journal of Clinical and Translational Hepatology|January 15, 2021
Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis BJoseph K Lim, Alex Y Chang, Atif Zaman, et al.
EMBO Molecular Medicine|August 26, 2018
Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axisAlexander Greenhough, Clare Bagley, Kate J Heesom, et al.
Blood|March 6, 2002
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in childrenAnn E Woolfrey, Claudio Anasetti, Barry Storer, et al.
Scientific Reports|December 21, 2023
Identification of differences in CD4<sup>+</sup> T-cell gene expression between people with asthma and healthy controlsMauro Tutino, Jenny Hankinson, Clare Murray, et al.
Gastroenterology|August 2, 2003
6-thioguanine can cause serious liver injury in inflammatory bowel disease patientsMarla C Dubinsky, Eric A Vasiliauskas, Hardeep Singh, et al.
Gastroenterology|June 10, 2006
Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis BMorris Sherman, Cihan Yurdaydin, Jose Sollano, et al.
Plos One|October 4, 2011
CYP17A1 intron mutation causing cryptic splicing in 17α-hydroxylase deficiencyDaw-Yang Hwang, Chi-Chih Hung, Felix G Riepe, et al.
Cancer|June 29, 2019
Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinomaLynn G Feun, Ying-Ying Li, Chunjing Wu, et al.
Elife|May 18, 2021
Live-imaging of endothelial Erk activity reveals dynamic and sequential signalling events during regenerative angiogenesisKazuhide S Okuda, Mikaela S Keyser, David B Gurevich, et al.
Pageof 85